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CholesterolThe modulation of the HDL receptor scavenger receptor B1 (SRB1) was evaluated in skin ﬁbroblasts
isolated from patients with Rett syndrome (RTT), a genetic form of infantile autism. Patients showed
an altered plasma lipid proﬁle, while their skin ﬁbroblasts showed a dramatic reduction in SRB1
(immunogold, Western blot and immunohistochemistry). The decreased SRB1 levels were demon-
strated to be the consequence of its binding with 4-hydroxy-2-nonenal (4HNE), a product of lipid
peroxidation, and its increased ubiquitination. Our ﬁndings show for the ﬁrst time a loss of SRB1
in RTT cells and its relationship with a chronic oxidative stress status.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Rett syndrome (RTT), is a severe neurological disorder affecting
almost exclusively females, with a frequency of approximately
1:10000 live births. Although it is a relatively rare condition, RTT
represents the second most common cause of severe mental retar-
dation in the female. In up to 95% of the cases causative mutations
in the X-linked methyl-CpG binding protein 2 gene (MeCP2) are
detectable, resulting in a wide genetical and phenotypical hetero-
geneity [1,2]. RTT is one of the so deﬁned autism spectrum disor-
ders (ASDs) and besides the ‘‘classic autism’’, includes Asperger
syndrome and the pervasive developmental disorder not otherwise
speciﬁed (PDD-NOS) [3]. Approximately half of the RTT patients do
not reach 40 years of age due to a remarkably increased risk for
sudden death [4]. Besides uncontrolled seizures, it is well known
that cardiorespiratory complications and lung infections are the
factors most strongly associated with an increased risk of sudden
unexplained death in RTT [5].Emerging evidence indicates that abnormalities in fatty acid
metabolism and membrane fatty acid composition may contribute
to neurodevelopment disorders including ASDs [6]. At present,
insufﬁcient research exists regarding the lipid proﬁle of girls with
RTT. Dyslipidemia is the elevation of plasma cholesterol (T-Chol),
triglycerides (TG), or both. We hypothesized that high-density
lipoprotein (HDL) level may contribute to the vascular and/or
respiratory complications observed in RTT [7–11]. However, to
our knowledge, no information exists regarding the plasma lipid
proﬁle in RTT patients. Therefore, this study was conducted to ana-
lyze the lipid proﬁle of RTT and evaluate the levels of the so called
‘‘HDL-receptor’’, better known as scavenger receptor B1 (SRB1)
using primary skin ﬁbroblasts isolated from RTT patients as a mod-
el. SRB1, a 82-kDa cell surface protein, is involved not only in the
binding of HDL thus promoting selective uptake of HDL lipids via
a hydrophobic channel, but it has now been shown that this recep-
tor is also involved in several other cellular processes, such as rec-
ognition of pathogens and apoptotic cells, as well as lipid soluble
antioxidants uptake; all conditions known to be present in the
clinical picture of RTT patients. In addition, SRB1 can be modulated
by oxidative stress (OS), either exogenous [12] or endogenous
[13,14], and the presence of chronic OS has been well documented
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markers and disease severity [16,17].
Therefore, in the present study, we hypothesized that RTT is
associated with an altered plasma lipoprotein proﬁle as a conse-
quence of SRB1 modulation by OS.
2. Methods
2.1. Subjects
A total of 151 female patients with classical RTT disorder
(mean age: 20.3 ± 12.3), as well as 50 healthy female controls
of comparable age (mean age: 19.2 ± 14.5) participated to the
study.
All the patients were consecutively admitted to the Child Neu-
ropsychiatry Unit of the University Hospital of Siena (Head: J.H.).
All the examined subjects were on a typical Mediterranean diet.
2.2. Determination of serum lipids levels
The subjects were fasted before taking the blood and serum lip-
ids were measured using speciﬁc diagnostic kits (HDL-cholesterol
plus 3rd generation and LDL-cholesterol plus 2nd generation,
respectively, COBAS).
2.3. Human skin ﬁbroblast cultures
Human skin ﬁbroblasts were isolated from 3-mm skin punch
biopsy (n = 25 for RTT and n = 15 for controls). Cells were cultured
in DMEM, containing 20% fetal calf serum (FCS) and antibiotics
(100 U/ml penicillin, 100 lg/ml streptomycin) (Lonza, Milan, Italy).
Cells were incubated at 37 C in a humidiﬁed atmosphere of 95%
air and 5% CO2 for 3 days. When ﬁbroblasts growing from the der-
mal pieces formed a conﬂuent layer, the dermal pieces were re-
moved and trypsin/EDTA mixture was added to separate
ﬁbroblasts. Cells were transferred to 25-cm2 culture ﬂasks (Falcon,
Perugia, Italy) and subcultured in 10% FCS/DMEM. Fibroblasts from
passage 3 to 5 were used for the experiments. For experiments
with the proteasome inhibitor MG132 (Calbiochem, Mialno, Italy)
the cells were either treated with or without MG132 (ﬁnal concen-
tration in culture 10 lM) dissolved in DMSO (ﬁnal concentration in
culture 0.01%), and incubated for 2 h at 37 C.
2.4. Immunocytochemistry
Fibroblasts were grown on coverslips at a density of 5  104
cell/ml, and then ﬁxed in 4% paraformaldehyde in PBS for 30 min
at 4 C as previously described [18]. After permeabilization the
coverslips were blocked in PBS (1% BSA) at RT for 1 h. Coverslips
were then incubated with primary and then with secondary anti-
bodies. Nuclei were stained with 1 lg/ml DAPI (Molecular Probes)
after removal of secondary antibodies. Coverslips were examined
by the Zeiss Axioplan2 light microscope equipped with epiﬂuores-
cence at 40 magniﬁcation. Negative controls for the immuno-
staining experiments were performed by omitting primary
antibodies. Images were acquired and analyzed with Axio Vision
Release 4.6.3 software.
2.5. Western blot analysis
Total cell lysates were extracted in RIPA buffer containing
50 mM Tris (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Nonidet
P-40, 1 mM EGTA, 0.1% SDS, 5 mM N-ethylmaleamide (Sigma–
Aldrich Corp.), protease and phosphatase inhibitor cocktails
(Sigma–Aldrich Corp.) as described before [13,18].Brieﬂy, 60 lg of boiled proteins were loaded onto 10% sodium
dodecyl sulphate–polyacrylamide electrophoresis gels. The gels
were electro-blotted onto nitrocellulose membranes and hen
blocked for 1 h in 3% milk. Membranes were incubated overnight
at 4 C with the primary antibody SRB1 (Novus Biologicals, Inc., Lit-
tleton, CO, USA) and with horseradish peroxidase-conjugated sec-
ondary antibody (BioRad, Milan, Italy). The blots were stripped
and re-probed with b-actin (Cell Signalling; Celbio, Milan, Italy)
as the loading control. Images of the bands were digitized and
the densitometry of the bands were performed using Image-J
software.
2.6. Immunogold labelling
Fibroblast cells (1  106 cell/ml) were ﬁxed, dehydrated and
embedded in LR-White Resin Hard Grade (TAAB Laboratories, Eng-
land, UK) as previously described [18]. For the immunogold label-
ling procedure, grids containing sections were incubated in 0.05 M
tris–buffered saline–Tween20 (TBST), pH 7.6, and free aldehyde
binding was quench using 0.1 M Glycine in PB and then non-spe-
ciﬁc protein binding was blocked using 5% NGS–1% BSA in TBST.
Samples were incubated overnight at 4 C in anti-SRB1 (1:100) in
2% NGS-TBST. After treatment with primary antibody were washed
and incubated in goat anti-rabbit IgG conjugated to 10 nm Gold
particles (BBInternational, Cardiff, UK). The grids were post-ﬁxed
and rinsed in TBST, stained in aqueous uranyl acetate and lead cit-
rate. The grids were examined and photographed using a Philips
CM10 transmission electron microscope. For negative control,
grids containing sections were incubated in 2% NGS-TBST without
the primary antibody.
2.7. Immunoprecipitation
Cell lysates containing 500 lg of protein were mixed with Dyn-
abeads protein G and incubated with 2 lg of polyclonal antibodies
overnight at 4 C in a total volume of 200 ll. The complexes were
precipitated by incubation with protein A-agarose (Boehringer
Mannheim) for 4 h at 4 C. Immunoprecipitates were washed ﬁve
times with IP buffer and once with PBS and then separated by
SDS–PAGE, electrotransferred to nitrocellulose membranes and
immunoblotted.
2.8. Statistical analysis
For all the variables tested, one-way analysis of variance (ANO-
VA) was used. Statistical signiﬁcance was indicated by a P-va-
lue <0.05. Data were expressed as mean ± S.D. from triplicate
determinations obtained in ﬁve separate experiments.3. Results
3.1. RTT subjects have high serum lipids levels
As showed in Table 1, when compared to healthy subjects, RTT
patients have a signiﬁcant increase in total-cholesterol (12%), LDL-
cholesterol (15%) and HDL-cholesterol (18%), respectively.3.2. SRB1 levels decrease in RTT subjects
SRB1 has been shown to be involved in the cholesterol uptake
from HDL and with less afﬁnity from LDL, therefore we assessed
the protein levels of SRB1 in both healthy subjects and RTT pa-
tients. As shown in Fig. 1A, ﬁbroblasts isolated from RTT patients
had signiﬁcant lower levels in SRB1 protein (ca. 35%, right panel)
compared to the control. As shown in Fig. 1B, the different content
Table 1
Serum lipids in Rett syndrome: comparisons with healthy controls (mean ± S.D.).
Rett Healthy controls P-Valuea
N 151 50
Total cholesterol (mg/dl) 186.9 ± 36.2 166 ± 5.9 0.0003**
Total triglycerides (mg/dl) 80.9 ± 33.9 81.4 ± 23.4 0.9008
LDL-cholesterol (mg/dl) 102.2 ± 31.3 87.5 ± 12.8 0.0071**
HDL-cholesterol (mg/dl) 60.1 ± 18.2 49.6 ± 12.3 0.0064**
a t-Test for paired samples.
** Statistically signiﬁcant difference.
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conﬁrmed by immunogold labeling analysis (decrease of ca. 75%).
3.3. Increased HNE levels and HNE–SRB1 adducts in RTT ﬁbroblasts
Increased levels of peroxidation [17] and oxidative stress (OS)
[19] have been well documented in RTT patients. For this reason
we evaluated the presence of 4HNE, which is a product of lipid per-
oxidation, the eventual formation of and 4HNE–SRB1 adducts. As
shown in Fig. 2A, in RTT ﬁbroblasts there was an increase in
4HNE protein adducts (ca. 40%, bottom panel) and IP assay
(Fig. 2B) evidenced the interaction between SRB1 and 4HNE in
RTT ﬁbroblasts respect to the control.
These results were conﬁrmed by double-immunocytochemistry
(ICC) assay for SRB1 and HNE. As shown in Fig. 2C, ICC conﬁrmedFig. 1. RTT ﬁbroblasts present low SR-B1 protein levels compared to health ﬁbroblasts. D
Western blot (top panel) is a representative of ﬁve experiments from ﬁve different patie
Data are expressed in arbitrary units (averages of ﬁve different experiments, ⁄P < 0.05). b-
blot data. Each black dot represents the receptor. Original magniﬁcation 39000.the low levels of SRB1 in RTT ﬁbroblasts (left column, red color)
with a concomitant increase of HNE (Fig. 2C, central column, green
color). The co-localization (yellow) appreciable in the right column
showed the presence of SRB1-4HNE adducts. The co-localization in
RTT ﬁbroblasts was barely perceptible due to the low levels of
SRB1. Therefore, as positive control, we treated normal ﬁbroblasts
with H2O2, generated by glucose oxidase (GO), to mimic an OS
event. As showed in Fig. 2C (bottom panel), in this conditions,
the control cells responded similarly to RTT ﬁbroblasts evidencing
a clear interaction between 4HNE and SRB1.
3.4. Increased ubiquitination and 4HNE protein adducts in RTT
ﬁbroblasts
It has been shown that covalent binding of 4HNE to protein
leads to protein modiﬁcations that can result in protein ubiqui-
tination and cause its degradation by the proteosome
machinery.
In the present experiment we want to determine whether there
was an interaction between 4HNE and the ubiquitin. As shown in
Fig. 3A, using the IP approach, RTT ﬁbroblasts presented a clear in-
crease in ubiquitination signal in relation to 4HNE. This was also
evident by ICC analysis (Fig. 3B); with the increase of 4HNE levels
(left column, green color) and in parallel there was an increased
ubiquitination signal (center column, red color). The right column
evidenced the co-localization (yellow) suggesting the co-presenceata are expressed as mean ± S.E.M. of ﬁve independent experiments (⁄P < 0.05). (A)
nts (from a total of eight). (B) SR-B1 bands uantiﬁcation is shown in the right panel.
Actin was used as loading control. (C) Immunogold for SRB1 conﬁrmed the Western
Fig. 2. RTT ﬁbroblasts present an increase in HNE/SRB1 adducts. (A) Fibroblasts lysates were immunoblotted (IB) for HNE adducts. Showed is a representative Western blot of
ﬁve experiments from ﬁve different patients. (B) Samples were immunoprecipitated (IP) with SRB1 Ab, and immunoblotted (IB) with anti-HNE. Western blot is representative
of ﬁve independent experiments. (C) Immunocytochemistry assay (ICC) shows the localization of SRB1 (left column, red colour) HNE-adducts (central column, green colour),
and HNE–SR-B1 adducts (right column, yellow colour). Images are merged in the right panel and the yellow colour indicates overlap of the staining.
Fig. 3. RTT ﬁbroblasts present an increase of Ubiquitin/HNE adducts. (A) Fibroblasts lysates were IP with Ubiquitin (Ub) Ab, the proteins were separated by SDS–PAGE, then IB
with anti-HNE. Western blot is representative of ﬁve independent experiments. (B) ICC shows the localization of HNE-adducts (left column, green colour), Ubiquitin (central
column, red colour) and Ub-HNE adducts (right column, yellow colour). Images are merged in the right panel and the yellow colour indicates overlap of the staining.
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trol ﬁbroblasts.
3.5. Increases ubiquitination in SRB1-4HNE protein adducts in RTT
ﬁbroblasts
Finally, we decided to evaluate whether the ubiquitination pro-
cess was involved in the post-translational modiﬁcation of SRB1protein in RTT ﬁbroblasts. As shown in Fig. 4A, there was an evi-
dent interaction between ubiquitin and SRB1, thus suggesting a
process of ubiquitination for SRB1. Using ICC techniques we were
able to conﬁrm the low level of SRB1 in RTT ﬁbroblasts (Fig. 4B, left
column, green color), the increased ubiquitination (central column,
red color) and the co-localization (right column, yellow color)
appreciable only in the RTT samples suggesting the formation of
SRB1-Ub adducts. The role of the proteosome in SRB1 degradation
Fig. 4. RTT ﬁbroblasts present an increase of SRB1/Ubiquitin adducts. (A) Fibroblasts lysates were IP with SRB1 Ab, the proteins were separated by SDS–PAGE, then IB with
anti-Ub. Western blot shown is representative of ﬁve independent experiments. (B) ICC shows the localization of SRB1-adducts (left column, green colour), Ubiquitin (central
column, red color) and SRB1-Ub adducts (right column, yellow colour). Images are merged in the right panel and the yellow colour indicates overlap of the staining.
Fig. 5. MG-132 treatment reverts the loss of SRB1 in RTT ﬁbroblast. Cell lysate were extracted from health ﬁbroblasts, RTT ﬁbroblasts and RTT ﬁbroblasts pre-treated with
MG-132 (proteosome inhibitor) for 2 h. Western blot is a representative of ﬁve experiments from ﬁve different patients. b-Actin was used as loading control.
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(Fig. 5). When RTT ﬁbroblasts were pretreated with MG132 the loss
of SR-B1 was reversed demonstrating that SRB1 is degraded via the
proteosome machinery.
4. Discussion
In the present study, we have found that RTT patients have an
altered plasma lipid proﬁle represented by high levels of HDL
and LDL. To our knowledge this is the ﬁrst report that analyze this
feature in RTT. In addition, this work suggests a possible posttrans-
lational mechanism in SRB1 which could explain the coexistence of
an altered lipid proﬁle in RTT patients. It has been well docu-
mented that SR-B1 mediates the selective uptake of cholesteryl es-
ters from HDL as well as LDL into the cells without internalizing
lipoprotein particles [20].
SRB1/KO mice have been established by the laboratories of Van
Berkel and Krieger as valuable experimental models for atheroscle-
rosis [21–23]. Their studies have shown that SRB1/KO mice have
signiﬁcant increase in plasma HDL and total cholesterol levels. Fur-
thermore, SRB1/KO animal showed abnormally large HDL particles
and can develop atherosclerotic lesions of the arteries and heart
with high plasma cholesterol concentrations. Beside these ﬁndings
from animal studies, no clear pathologies have been so far clearly
related to abnormal SRB1 expression, although several other func-
tions for SRB1 have been now recognized [14]. In fact in last few
years, the role of SRB1 has been studied under several physio-path-
ological conditions. For instance SRB1 has been identiﬁed as a
putative receptor for hepatitis C virus (HCV) [24]. Furthermore,
Baranova et al. [25] have shown that the major component of the
outer membrane of Gram-negative bacteria (lipopolysaccharide –
LPS) is able to downregulate both mRNA and protein levels of
SRB1 in an NF-kB-mediated mechanism. In addition, a recent study
has shown that SRB1 could be also involved in the recognition of
dsRNA [26]. These data suggest that SRB1 recognizes danger sig-nals associated with lytic virus infections and from bacterial. In-
deed, respiratory viruses produced dsRNA and these infections
are associated with the production of ligands released by dead cells
probably including modiﬁed proteins during the death process.
Whether or not the generation of endogenous ligands inhibits im-
mune responses following infection with dsRNA-producing respi-
ratory viruses is still unknown but it is possible to speculate that
SRB1 may represent a possible novel target for therapeutic or pre-
ventive interventions that aim to control virus-associated immun-
opathologies. This is in line with unpublished observation from our
group (JH) where RTT patients encounter an evident increased fre-
quency of lung infections sometimes leading to their death. SRB1 is
also involved in vitamin E tissue absorption in a mechanism simi-
lar to that of cholesterol uptake, indeed it has been shown that SR-
B1-deﬁcient mice have ca. 50% less tissue a-tocopherol [27]
(Fig. 2).
This evidence, together with the ﬁnding that forced expression
of SRB1 induced cellular uptake of HDL a-tocopherol indicates that
SRB1 has a role in the uptake of a-tocopherol from plasma HDL to
tissues. As studies have shown that oxidant-related lung damage is
enhanced deﬁcient of vitamin E deﬁcient [28], it is possible that
also this aspect is also involved in the pathological features
encountered in RTT patients [29]. Thus SRB1 can be considered a
multifunctional receptor [14]. Emerging evidences have indicated
that SRB1 protein levels are downregulated by oxidative stress
(imbalance between oxidants and antioxidants molecules) both
from both exogenous (i.e., cigarette smoke and ozone) [18,13]
and endogenous (i.e., aging) sources [12]. In the present work,
we have shown that the loss of SRB1 is a consequence of post-tras-
lational modiﬁcations related to the covalent binding with 4HNE
and to the subsequent ubiquitination, which led to SRB1 degrada-
tion by the proteosome. Indeed, the use of the proteosome inhibi-
tor MG132 reversed the effect.
The binding of ubiquitin to a protein serves as a signaling mech-
anism for degradation of the selected protein. The rate of protein
2204 C. Sticozzi et al. / FEBS Letters 587 (2013) 2199–2204degradation is altered in neuropathologies such as Alzehimer, Par-
kinson and Algelman and Rett syndrome (Lehman NL 2009, Acta
Neurotpahol) where the existence of OS has been well
demonstrated.
The presence of systemic OS in RTT patients has been well
established [19,16,17]. 4HNE which, is formed from arachidonic
acid or other unsaturated fatty acids following free radical attack
can bind, by Michael addition to proteins, particularly to cysteine,
hystidine, or lysine residues [30]. For this reason, 4HNE-PAs are
considered not only a reliable marker of OS but thanks to its ability
to form adducts to the proteins, 4HNE has also a biological impact
by changing protein functions.
Interestingly, a previous report by our group has shown the
presence of radiological features in RTT patients, closely resem-
bling those of respiratory bronchiolitis-associated interstitial lung
disease (RB-ILD), a lung pathology typically related to CS [29]. To
this regard, exposure to CS has been previously shown to induce
the loss of SRB1 protein both in vivo and in vitro [12,13] and in par-
ticular, the cell study has evidenced an increased SRB1 ubiquitina-
tion, as we have shown in RTT skin ﬁbroblasts [18].
Therefore SRB1 can be a molecular bridge between RTT and OS
mediated lung diseases. Moreover, it is possible that the protein
fate observed for SRB1 could be shared by several other proteins
not yet known at this time.
The results of this study point out several outcomes. Firstly, the
loss of SRB1 is a previously unrecognized feature of RTT. Secondly,
down-regulation of SRB1 could explain some of the clinical fea-
tures of RTT such as hyperlipidemia, lung infections and respira-
tory bronchiolitis. Thirdly, by documenting the presence of 4HNE
(marker of oxidative stress), we further conﬁrm at the tissue level
the coexistence of a systemic redox status alteration, previously
documented by us in blood samples from RTT patients [15]. Finally,
it is important to underline that primary cultured skin ﬁbroblasts
isolated from patients prove to be a good model for a better under-
standing of the molecular aspects linking theMeCp2 gene mutation
to the disease phenotypic expression.
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